Trusted Resources: Education
Scientific literature and patient education texts
Understanding Bias When Estimating Life Expectancy From Age at Death: A Simulation Approach Applied to Morquio Syndrome A
source: BMC research notes
year: 2022
authors: Yin X,Ahn J,Boca SM
summary/abstract:Life expectancy can be estimated accurately from a cohort of individuals born in the same year and followed from birth to death. However, due to the resource-consuming nature of following a cohort prospectively, life expectancy is often assessed based upon retrospective death record reviews. This conventional approach may lead to potentially biased estimates, in particular when estimating life expectancy of rare diseases such as Morquio syndrome A. We investigated the accuracy of life expectancy estimation using death records by simulating the survival of individuals with Morquio syndrome A under four different scenarios.
organization: Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, DC, USA.DOI: 10.1186/s13104-021-05894-0
read more
Related Content
-
Story of Annabelle With MPS IV (A)When Annabelle’s mom noticed a small h...
-
Molecular Characterization of Mucopolysaccharidosis Type IVA Patients in the Andean Region of ColombiaColombia has a high prevalence of mucopo...
-
Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A SyndromeMucopolysaccharidosis type IVA (MPS IVA ...
-
Differences in Gene Expression Patterns, Revealed by RNA-Seq Analysis, Between Various Sanfilippo and Morquio Diseas...Mucopolysaccharidoses (MPS) are genetic ...
-
Clinical Features and Health-Related Quality of Life in Adult Patients With Mucopolysaccharidosis IVA: The Spanish E...Mucopolysaccharidosis (MPS) IVA or Morqu...
-
Treatment of Skeletal and Non-Skeletal Alterations of Mucopolysaccharidosis Type IVA by AAV-Mediated Gene TherapyMucopolysaccharidosis type IVA (MPSIVA) ...
-
Plasma Proteomic Analysis in Morquio A DiseaseMucopolysaccharidosis type IVA (MPS IVA)...